Genomic, hormonal, and anthropometric factors as crucial contributors to male infertility in Abeokuta, Southwestern Nigeria

Main Article Content

ADEBAYO A. AMBALLI
WASIU E. OLOOTO
OLAYINKA T. KOSOKO
FOLARIN O. OWAGBORIAYE

Abstract

Abstract. Amballi AA, Olooto WE, Kosoko OT, Owagboriaye FO. 2025. Genomic, hormonal, and anthropometric factors as crucial contributors to male infertility in Abeokuta, Southwestern Nigeria. Asian J Trop Biotechnol 22: 16-22. The failure to get pregnant despite regular, unprotected sexual intercourse among couples has psychosocial and socioeconomic impacts. This study aims to investigate the contributions of anthropometric, genomic, and hormonal factors to male infertility. Hence, 48 infertile men and 12 men with proven fertility, aged from 26 to 55 years, were selected as cases and controls, respectively. Anthropometric measurements (height and weight) were done, Body Mass Index (BMI) was computed, and serum Follicle-Stimulating Hormones (FSH), Luteinizing Hormones (LH), and testosterone were measured. Semen was obtained for seminal fluid analysis and phenotyping assay. There is no significant change in the anthropometric indicators (height, weight, BMI); 4.2% of the infertile men were normospermic, 20.8% were azoospermic, and 75% were oligospermic. There was an increase in FSH, LH, and testosterone in all the infertile subgroups and a significant decrease (p < 0.05) in sperm count in infertile males. While 70% of sperm cells exhibited fast movement in the controls, sperm movement was 9.5, 5.5, and 15% normal, slow, and non-motile, respectively, among infertile men. The percentage of deletions in Azoospermia Factor a (AZFa) region using sY84 and sY86 was 66.7%, and none in the control group. It can be concluded that high plasma levels of gonadotrophins, low sperm count, and high levels of testosterone are pathognomonic of male infertility. While the deletion of AZFa region is conclusively indicative of infertility, its non-deletion does not conclusively indicate fertility; thus, factors other than hormonal abnormalities are associated with male infertility.

Article Details

Section

Articles

Author Biographies

ADEBAYO A. AMBALLI, Department of Chemical Pathology and Immunology, Faculty of Basic Medical Sciences, Olabisi Onabanjo University. Hospital Road, Ogun State, Nigeria

Department: Chemical Pathology

Rank: Associate Professor

WASIU E. OLOOTO, Department of Chemical Pathology and Immunology, Faculty of Basic Medical Sciences, Olabisi Onabanjo University. Hospital Road, Ogun State, Nigeria

Department of Chemical Pathology

References

Sezgin G, Mehmet AA, Gulgez NTH, Ramazan A. The role of epigenetics in idiopathic male infertility. J Assist Reprod Genet. 2016;33(5):553–569.

American Society for Reproductive Medicine. Diagnostic eval___uation of the infertile male: a committee opinion. Fertil Steril. 2015;103:18-25.

Barak S, Baker HWG. Clinical management of male infertility. In: Jameson JL, De Groot LJ, de Kretser DM, et al, eds. Endocrinology: Adult and Pediatric. 7th ed. Philadelphia, PA: Elsevier Saunders;2016:chap 141.

Tianwen H, Xiangzhong Z, Hua D, Weiping Z, Xin Z, Hui Z, Jian Lu, Yichun Z, Changbin Z, Liang Z, Aihua Y. A novel Y chromosome microdeletion potentially associated with defective spermatogenesis identified by custom array comparative genome hybridization. Reproductive BioMedicine Online 2016;34(2017):75–81.

Rabinowitz MJ, Huffman PJ, Haney NM, Kohn TP. Y- chromosome microdeletions: A review of preval___ence, screening, and clinical considerations. 2021; 14: 51–69 doi:10.2147/TACG.S267421

Khon TP, Khon JR, Owen RC, Coward RM. The Preval___ence of Y-chromosome Microdeletions in Oligozoospermic Men: A Systematic Review and Meta-analysis of European and North American Studies. Eur Urol. 2019; 76(5) : 6626-636 doi:/10.1016/J.eururo.2019.07.033

Liu JL, Pena V, Fletcher SA, Kohn TP. Genetic testing in testing in male infertility – reassessing screening thresholds. Curr. opin. urol. 2020; 30(3) : 317-323 dio:/10.1097/mov.0000000000000764

Olooto WE, Olawale OO, Amballi AA, Ezima NE, Ogundahunsi AO. Plasma Lipid profile and Hepatic Transaminase activities as Indicator of Cardiovascular disorder and Hepatocellular damage in Type 2 Diabetes Mellitus Patients. African Journal of Science and Nature, 2016;3:10-16.

Centers for Disease Control and Prevention (United States Chapter). BMI categories for adults March 2024; www.cdc.gov

World Health Organization. WHO Laboratory manual for the examination and processing of human semen, 5th edition, Cambridge, Cambridge University Press, 2010.

Fahie-Wilson M. Detection of Macroprolactin Causing Hyperprolactinemia in Commercial Assays for Prolactin. Clin Chem 2000; 46:1993-1995.

Wang J, Christina Fan H, Behr B, Quake RS. Genome-Wide Single-Cell analysis of recombination activity and de novo mutation rates in human sperm cell 2012;150(2):402-412.

Lee RK, Hou J, Ho H, Hwu Y, Lin M, Tsai Y, Su J. Sperm morphology analysis using strict criteria as a prognostic factor in intrauterine insemination. International Journal of Andrology 2002;25:277-280.

Miller SA, Dykes DD. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.

Krausz C, Hoefsloot L, Simoni M, Tutteimann F. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013. Andrology 2014;2(1):5–19.

Devini A, Alpha G, Akwasi A. Obesity and male infertility, Best pract Res Clin Obstet Gynaecol 2023; Aug:90: 102393, doi:/10.1016/J.bpobgyn.2023.102393.

Chaudhuri GR, Das A, Bandhukesh S, Charya KB, Dutte S, Sengupta P, Syamal AK. O besity and male infertility: multifaceted reproductive disruption. Middle east fertility society journal, 2022; 27,8. https://doi.org/10.1186/S43043-022-00099-2

Oztekin U, Caniklioglu M, Sari S, Gurel A, Selmi V, Isikay L. The impact of BMI on reproductive hormones, testosterone/estradiol ratio and semen parameters. Central European J. Urol. 2020; June 12;73(2): 226-230. doi:10.5173/ceju.2020.0020.

Nunes DC, Ribeiro JC, Alves MG, Oliveria PF, Bernardino RL. Male Sex Hormones, Metabolic Syndrome, and Aquaporins: A Triad of Players in Male (in) Fertility. Int. J. Mol. Sci. 2023; 24(3), 1960; https://doi.org/10.3390/ijms24031960

Concepcion-zavaleta M, Ibarra JLP, Yataco AR, Coronado-Arroyo J, Concepcion-urteaga L, Roseboom PJ, Williams CA. Assessment of hormonal status in male infertility. An Update. Diabetes and Metabolic Syndrome: Clinical Research and Reviews.2022; vol 16 (3), 102447. https://doi.org/10.1016/J.dsx.2022.102447

Salama N, Blgozah S. Serum Estradiol levels in infertile men with non-obstructive azoospermia. Therapeutic Advances in Reproductive Health. 2020; https://doi.org/10.1177/26334941.20928342.

Dabbous Z, Atkin SL. Hyperprolactinaemia in male infertility: clinical case scenarios. Arab Journal of Urology. 2018; vol 16(1): 44-52

Radhakrishnan D, Kumaresan R, Nagamurugan. Preval___ance of male infertility in India: Studies on the effects of gonadotropin releasing hormones. Asian Journal of Pharmaceutical and Clinical. 2017; 10 (8).

Levine H, Jorgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Jolles M, Pinotti R, Swan SH. Temporal trends in sperm count: a systematic review and metaregression analysis of samples collected globally in the 20th and 21st centuries. Human Reprod update. 2023; 29(2): 157-176. doi:10.1093/humupd/dmx022

Bani SB, Anachem R, Banyeh M, Dapare PM, Adams Y, Nkansah C, Mensah K, Samuel KA and Bani F, Osumanu H, Gabriel A, Samira D. Study on Semen Quality among Men Seeking Infertility Treatment in Tamale, Ghana. Asian Journal of Research and Reports in Urology 2023; 6 (1). pp. 27-36.

Agarwal A, Rakesh S, Sajal G, Renata F, Neel P, et al. Sperm Morphology Assessment in the Era of Intracytoplasmic Sperm Injection: Reliable Results Require Focus on Standardization, Quality Control, and Training. World journal of men’s Health. 2021; June 17; 40(3) : 347-360

Suresh CS, Ahmet A Standardized Semen Analysis and Quality Control Management for Multicenter Male Reproductive Toxicology Clinical Trials in Bioenvironmental Issues Affecting Men's Reproductive and Sexual Health, academy press, 2018;Pages 371-386

Dcunha R, Hussein RS, Ananda H, Kumari S, Adiga SK, Kannan N, Zhao Y, Kalthur G. Current Insights and Latest Updates in Sperm Motility and Associated Applications in Assisted Reproduction. Reprod sci. 2020 Dec. 7; 29(1): 7-25. doi:10.1007/s43032-020-00408-y

Liu, T., Yu-Xin S, Yong-Mei J (2019) Early detection of Y chromosome microdeletions in infertile men is helpful to guide clinical reproductive treatments in southwest of China, Medicine (Baltimore). 2019; 98(5): e14350.

Lavanya and Poongothai, 2017 Screening of Y-Chromosomal Microdeletions Using 8 STS Primers in Idiopathic Infertile Men from Coimbatore District, Tamilnadu, 2(10), International Journal of Innovative Science and Research Technology, 614-620